Bio-Works Technologies AB (BIOWKS) - Total Liabilities
Based on the latest financial reports, Bio-Works Technologies AB (BIOWKS) has total liabilities worth Skr21.55 Million SEK (≈ $2.32 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bio-Works Technologies AB - Total Liabilities Trend (2015–2025)
This chart illustrates how Bio-Works Technologies AB's total liabilities have evolved over time, based on quarterly financial data. See BIOWKS net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Bio-Works Technologies AB Competitors by Total Liabilities
The table below lists competitors of Bio-Works Technologies AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Team Young Advanced Technology Co Ltd
TWO:5345
|
Taiwan | NT$6.42 Million |
|
ITV PLC
LSE:ITV
|
UK | GBX2.36 Billion |
|
Kentucky First Federal Bancorp
NASDAQ:KFFB
|
USA | $324.88 Million |
|
Alpine Summit Energy Partners Inc
NASDAQ:ALPS
|
USA | $12.97 Million |
|
DP Aircraft I Limited
LSE:DPA
|
UK | $95.47 Million |
|
Coda Minerals Ltd
AU:COD
|
Australia | AU$1.60 Million |
|
CORESTATE Capital Holding S.A
F:CCAP
|
Germany | €725.00 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Bio-Works Technologies AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bio-Works Technologies AB market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bio-Works Technologies AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bio-Works Technologies AB (2015–2025)
The table below shows the annual total liabilities of Bio-Works Technologies AB from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr21.55 Million ≈ $2.32 Million |
+172.34% |
| 2024-12-31 | Skr7.91 Million ≈ $851.57K |
-56.33% |
| 2023-12-31 | Skr18.12 Million ≈ $1.95 Million |
-24.25% |
| 2022-12-31 | Skr23.92 Million ≈ $2.57 Million |
+93.65% |
| 2021-12-31 | Skr12.35 Million ≈ $1.33 Million |
+53.57% |
| 2020-12-31 | Skr8.04 Million ≈ $865.66K |
+36.48% |
| 2019-12-31 | Skr5.89 Million ≈ $634.29K |
+2.26% |
| 2018-12-31 | Skr5.76 Million ≈ $620.30K |
-3.76% |
| 2017-12-31 | Skr5.99 Million ≈ $644.51K |
+35.01% |
| 2016-12-31 | Skr4.44 Million ≈ $477.38K |
+92.79% |
| 2015-12-31 | Skr2.30 Million ≈ $247.62K |
-- |
About Bio-Works Technologies AB
Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chr… Read more